HLA-DR15 is associated with lower age at onset in multiple sclerosis
Related Experiment Video
Updated: Oct 13, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
T Masterman1, A Ligers, T Olsson
1Department of Neurology, Karolinska Institutet at Huddinge University Hospital, Sweden.
Abstract:
To date, more than a dozen studies have investigated the role of HLA genes in determining clinical course and disease severity in multiple sclerosis (MS); in each of these studies, however, patient sample size has been small, and no consistent pattern has emerged from the results. For the present study, we determined HLA class II genotypes and catalogued clinical and demographic data for a total of 948 patients, making our data set the largest ever used to investigate HLA genes in MS. Our goals were both to investigate the impact of HLA-DRB1 alleles on clinical course and disease severity in MS and to compare the frequencies of the established susceptibility allele DR15 in various clinicodemographic subgroups of MS patients. We found that, in addition to DR15, DR17 is positively associated with susceptibility to MS; that none of the HLA-DRB1 alleles influences course or outcome in MS; that carriers of DR15 are prone to MS development at an earlier age than noncarriers; and that differences in DR15 positivity rates, after stratification for diagnostic category and examination results, seem to reflect a gradient of phenocopy contamination, with rates increasing in proportion to the degree of clinical or paraclinical verification of the MS diagnosis.
Insights
Human Leukocyte Antigen (HLA) genes DR15 and DR17 are associated with multiple sclerosis (MS) susceptibility. However, HLA-DRB1 alleles do not impact MS disease course or severity, though DR15 carriers may develop MS earlier.
Area of Science:
- Immunogenetics
- Neuroimmunology
- Human Genetics
Background:
- Multiple sclerosis (MS) is a chronic neurological disease with a complex etiology.
- Human Leukocyte Antigen (HLA) genes are known to influence MS susceptibility, but previous studies had small sample sizes.
- Consistent patterns regarding HLA gene impact on MS clinical course and severity have been lacking.
Purpose of the Study:
- To investigate the impact of HLA-DRB1 alleles on the clinical course and disease severity in MS.
- To compare the frequencies of the DR15 susceptibility allele in various clinicodemographic subgroups of MS patients.
- To identify novel HLA associations with MS susceptibility using the largest dataset to date.
Main Methods:
- Genotyping of HLA class II alleles in 948 MS patients.
- Cataloguing of clinical and demographic data for all participants.
- Statistical analysis to correlate HLA genotypes with MS susceptibility, clinical course, and disease severity.
Main Results:
- HLA-DR17, in addition to DR15, is positively associated with MS susceptibility.
- No investigated HLA-DRB1 alleles were found to influence the clinical course or outcome of MS.
- DR15 carriers were found to develop MS at an earlier age compared to non-carriers.
- DR15 positivity rates varied across diagnostic categories, potentially reflecting phenocopy contamination.
Conclusions:
- HLA-DR15 and DR17 are confirmed as susceptibility alleles for MS.
- HLA-DRB1 alleles do not appear to be determinants of MS disease progression or severity.
- Early-onset MS is associated with DR15 carriage.
- Further research is needed to understand the role of HLA in MS pathogenesis and to refine diagnostic criteria.
Related Concept Videos
Multiple Sclerosis l: Introduction
Alzheimer Disease l: Introduction
Type I Diabetes I: Introduction
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Huntington Disease l: Introduction
